Summary
Health experts in the U.S. are discussing whether to change the timing of the hepatitis B vaccine given to newborns. This vaccine has been administered at birth since 1991 and has greatly reduced childhood infections. Delaying this vaccination could potentially increase the risk of children contracting the virus.
Key Facts
- The hepatitis B vaccine is currently given to newborns in the U.S. right after birth.
- The Advisory Committee on Immunization Practices may vote to delay the hepatitis B vaccine for newborns.
- Some experts believe delaying the vaccine could increase the number of hepatitis B cases.
- Hepatitis B is a virus that affects the liver and spreads through contact with bodily fluids.
- The vaccine has helped decrease childhood infections by 95% since 1991.
- Delaying the vaccine could lead to more liver diseases and cancers as the children age.
- Hepatitis B often shows no symptoms, making it hard to diagnose without tests.
